IMG_Nov82021at20536PM.jpg
ImplantsAlcon Eyes Another Run at the MIGS Market Through IvantisAlcon Eyes Another Run at the MIGS Market Through Ivantis
The Geneva, Switzerland-based company has announced its intention to acquire Ivantis for $475 million.
Sign up for the QMED & MD+DI Daily newsletter.